Live birth after 6 years of oocyte vitrification in a survivor with breast cancer

Journal of Assisted Reproduction and Genetics

Volumn 31, Issue 10, 2014, Pages 1397-1400

  da Motta, Eduardo Leme Alves ^a,b,c   Bonavita, Monique ^b   Alegretti, José Roberto ^a   Chehin, Maurício ^a   Serafini, Paulo ^a,b,d  

^a Huntington Reproductive Medicine   (Brazil)

^b Hospital e Maternidade Santa Marina   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN; KI 67 ANTIGEN; LEUPRORELIN; PROGESTERONE RECEPTOR; PROTEIN P53; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; BLASTOCYST; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVOR; CASE REPORT; CESAREAN SECTION; DRUG DOSE REDUCTION; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR ASPIRATION; FOLLITROPIN BLOOD LEVEL; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LIVE BIRTH; LYMPH NODE DISSECTION; OOCYTE VITRIFICATION; OVARIAN RESERVE; PREGNANCY OUTCOME; REPRODUCTIVE PROCEDURE; SEGMENTAL MASTECTOMY; TRANSVAGINAL ECHOGRAPHY; BREAST TUMOR; OOCYTE; OOCYTE RETRIEVAL; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PROCEDURES; VITRIFICATION;

ADULT; BREAST NEOPLASMS; FEMALE; FERTILIZATION IN VITRO; HUMANS; LIVE BIRTH; OOCYTE RETRIEVAL; OOCYTES; PREGNANCY; VITRIFICATION;

EID: 84918514661     PISSN: 10580468     EISSN: 15737330     Source Type: Journal    
DOI: 10.1007/s10815-014-0314-0     Document Type: Article

References (18)

1. Youlden DR, Cramb SM, Dunn NA, Muller JM, Pyke CM, Baade PD. The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol. 2012;36:237–48.
2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29.
3. Reddy J, Oktay K. Ovarian stimulation and fertility preservation with the use of aromatase inhibitors in women with breast cancer. Fertil Steril. 2012;98:1363–9.
4. Cobo A, Domingo J, Perez S, Crespo J, Remohi J, Pellicer A. Vitrification: an effective new approach to oocyte banking and preserving fertility in cancer patients. Clin Transl Oncol Off Publ Fed Span Oncol Soc Natl Cancer Inst Mex. 2008;10:268–73.
5. Smith GD, Motta EE, Serafini P. Theoretical and experimental basis of oocyte vitrification. Reprod Biomed Online. 2011;23:298–306.
6. Vajta G, Kuwayama M. Improving cryopreservation systems. Theriogenology. 2006;65:236–44.
7. Martinez-Burgos M, Herrero L, Megias D, Salvanes R, Montoya MC, Cobo AC, et al. Vitrification versus slow freezing of oocytes: effects on morphologic appearance, meiotic spindle configuration, and DNA damage. Fertil Steril. 2011;95:374–7.
8. Rodriguez-Wallberg KA, Oktay K. Fertility preservation in women with breast cancer. Clin Obstet Gynecol. 2010;53:753–62.
9. Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol Off J Am Soc Clin Oncol. 2013;31:2500–10.
10. ASRM PCo. Mature oocyte cryopreservation: a guideline. Fertil Steril. 2013;99:37–43.
11. Rienzi L, Romano S, Albricci L, Maggiulli R, Capalbo A, Baroni E, et al. Embryo development of fresh ‘versus’ vitrified metaphase II oocytes after ICSI: a prospective randomized sibling-oocyte study. Hum Reprod. 2010;25:66–73.
12. Ubaldi F, Anniballo R, Romano S, Baroni E, Albricci L, Colamaria S, et al. Cumulative ongoing pregnancy rate achieved with oocyte vitrification and cleavage stage transfer without embryo selection in a standard infertility program. Hum Reprod. 2010;25:1199–205.
13. Garcia-Velasco JA, Domingo J, Cobo A, Martinez M, Carmona L, Pellicer A. Five years’ experience using oocyte vitrification to preserve fertility for medical and nonmedical indications. Fertil Steril. 2013;99:1994–9.
14. Noyes N, Porcu E, Borini A. Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies. Reprod Biomed Online. 2009;18:769–76.
15. Grifo JA, Noyes N. Delivery rate using cryopreserved oocytes is comparable to conventional in vitro fertilization using fresh oocytes: potential fertility preservation for female cancer patients. Fertil Steril. 2010;93:391–6.
16. Parmegiani L, Garello C, Granella F, Guidetti D, Bernardi S, Cognigni GE, et al. Long-term cryostorage does not adversely affect the outcome of oocyte thawing cycles. Reprod Biomed Online. 2009;19:374–9.
17. Cobo A, Garcia-Velasco JA, Domingo J, Remohi J, Pellicer A. Is vitrification of oocytes useful for fertility preservation for age-related fertility decline and in cancer patients? Fertil Steril. 2013;99:1485–95.
18. Kuwayama M. Highly efficient vitrification for cryopreservation of human oocytes and embryos: the Cryotop method. Theriogenology. 2007;67:73–80.